These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12461001)

  • 1. Identification and characterization of a novel efflux-related multidrug resistance phenotype in Staphylococcus aureus.
    Kaatz GW; Moudgal VV; Seo SM
    J Antimicrob Chemother; 2002 Dec; 50(6):833-8. PubMed ID: 12461001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus.
    Gibbons S; Oluwatuyi M; Kaatz GW
    J Antimicrob Chemother; 2003 Jan; 51(1):13-7. PubMed ID: 12493782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the existence of a multidrug efflux transporter distinct from NorA in Staphylococcus aureus.
    Kaatz GW; Seo SM; O'Brien L; Wahiduzzaman M; Foster TJ
    Antimicrob Agents Chemother; 2000 May; 44(5):1404-6. PubMed ID: 10770791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus.
    Schmitz FJ; Fluit AC; Lückefahr M; Engler B; Hofmann B; Verhoef J; Heinz HP; Hadding U; Jones ME
    J Antimicrob Chemother; 1998 Dec; 42(6):807-10. PubMed ID: 10052906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducible NorA-mediated multidrug resistance in Staphylococcus aureus.
    Kaatz GW; Seo SM
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2650-5. PubMed ID: 8592996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms and frequency of resistance to gatifloxacin in comparison to AM-1121 and ciprofloxacin in Staphylococcus aureus.
    Ince D; Hooper DC
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2755-64. PubMed ID: 11557465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus.
    Markham PN; Westhaus E; Klyachko K; Johnson ME; Neyfakh AA
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2404-8. PubMed ID: 10508015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial activity of Mimosa caesalpiniifolia Benth and its interaction with antibiotics against Staphylococcus aureus strains overexpressing efflux pump genes.
    Silva SWC; Monção NBN; Araújo BQ; Arcanjo DDR; Ferreira JHL; Lima Neto JS; Citó AMGL; de Siqueira Júnior JP; Kaatz GW; Barreto HM
    Lett Appl Microbiol; 2019 Jul; 69(1):57-63. PubMed ID: 31002429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus.
    Aeschlimann JR; Dresser LD; Kaatz GW; Rybak MJ
    Antimicrob Agents Chemother; 1999 Feb; 43(2):335-40. PubMed ID: 9925528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrophilicity of quinolones is not an exclusive factor for decreased activity in efflux-mediated resistant mutants of Staphylococcus aureus.
    Takenouchi T; Tabata F; Iwata Y; Hanzawa H; Sugawara M; Ohya S
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1835-42. PubMed ID: 8843290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the activities of fluoroquinolones against Staphylococcus aureus and the effect of reserpine on these activities].
    Zhong L; Feng P; Fan X; Lü X; Yu R; Liao F; Lei B
    Hua Xi Yi Ke Da Xue Xue Bao; 2002 Jan; 33(1):91-3. PubMed ID: 12599439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efflux-mediated response of Staphylococcus aureus exposed to ethidium bromide.
    Couto I; Costa SS; Viveiros M; Martins M; Amaral L
    J Antimicrob Chemother; 2008 Sep; 62(3):504-13. PubMed ID: 18511413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The multidrug efflux pump NorA is not required for salicylate-induced reduction in drug accumulation by Staphylococcus aureus.
    Price CT; Kaatz GW; Gustafson JE
    Int J Antimicrob Agents; 2002 Sep; 20(3):206-13. PubMed ID: 12385700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus.
    Kaatz GW; Seo SM; Ruble CA
    Antimicrob Agents Chemother; 1993 May; 37(5):1086-94. PubMed ID: 8517696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hydrophobicity and molecular mass on the accumulation of fluoroquinolones by Staphylococcus aureus.
    Piddock LJ; Jin YF; Griggs DJ
    J Antimicrob Chemother; 2001 Mar; 47(3):261-70. PubMed ID: 11222558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump.
    Sabatini S; Kaatz GW; Rossolini GM; Brandini D; Fravolini A
    J Med Chem; 2008 Jul; 51(14):4321-30. PubMed ID: 18578473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of NorA inhibition on the activities of levofloxacin, ciprofloxacin and norfloxacin against two genetically related strains of Staphylococcus aureus in an in-vitro infection model.
    Aeschlimann JR; Kaatz GW; Rybak MJ
    J Antimicrob Chemother; 1999 Sep; 44(3):343-9. PubMed ID: 10511401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter.
    Neyfakh AA; Borsch CM; Kaatz GW
    Antimicrob Agents Chemother; 1993 Jan; 37(1):128-9. PubMed ID: 8431010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of active efflux in resistance to ciprofloxacin and to ethidium bromide by Mycoplasma hominis.
    Raherison S; Gonzalez P; Renaudin H; Charron A; Bébéar C; Bébéar CM
    Antimicrob Agents Chemother; 2002 Mar; 46(3):672-9. PubMed ID: 11850247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic and genotypic characterisation of multiple antibiotic-resistant Staphylococcus aureus exposed to subinhibitory levels of oxacillin and levofloxacin.
    Jo A; Ahn J
    BMC Microbiol; 2016 Jul; 16(1):170. PubMed ID: 27473500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.